Scalable Technology for Online Prevention of Child Sexual Abuse (CSA) and CSA Materials
STOP-CSAM
2 other identifiers
interventional
180
2 countries
2
Brief Summary
- 1.Summary The STOP-CSAM Study is a two-armed randomized controlled trial of a non-pharmacological Therapy Chat Service for prevention of Child Sexual Abuse (CSA) and Child Sexual Abuse Materials (CSAM) in self-referred and self motivated patients with high frequent CSAM use and non-detected by the legal authorities.
- 2.Trial design This study is a prospective multicentred, stratified, parallel-group superiority study conducted in Germany, Czechia and Spain.
- 3.Background There has been a significant increase in child sexual abuse material (CSAM) on the internet in recent years. The use of CSAM is problematic especially because it creates a demand for and maintains contact child sexual abuse. Unfortunately, despite the significant increase in the number of CSAM users, limited resources are available for investigation and prosecution. Consequently, many users remain in the community, with neither intervention from the criminal justice system, nor the health system. The proposed study will examine whether a therapy chat service (TCS) intervention reduces the demand for, circulation and spread of CSAM in undetected offenders, as compared to a control group.
- 4.Methods The sample consists of individuals aged 18 years or older (expected N = 630), who have used CSAM in the prior two weeks and are seeking help voluntarily. Participants will be randomized to (1) a Therapy Chat Service (TCS) intervention or (2) a four-week waitlist (control group) followed by a TCS intervention. The TCS intervention group will receive four to six one-hour online therapy chat sessions over the period of four weeks, while the control group will remain on a waitlist for these four weeks before receiving the same TCS intervention. Assessments will be conducted at baseline (pre-intervention) and at 4-, 8-, 12- and 16-weeks post-intervention. The main objective of the study is to compare the effectiveness of TCS in the prevention of CSAM use within a sample of self-referred participants. The primary outcome is the significant decrease of CSAM consumption, which will be assessed by comparing self-reported severity and time spent using CSAM in the two weeks before the intervention and at four weeks following the intervention. Potential progress measures include time spent, severity and frequency of CSAM consumed. Psychological wellbeing and total sexual outlet will be also measured as secondary outcomes, other participant variables such as risk factors for CSAM consumption or sexual interests and therapeutic variables such as number of patient-therapist interactions, modules covered per session, common factors of psychotherapy, adverse effects of intervention and dropout rate will be also measured. Outcomes between groups will be compared following standard principles for RCTs.
- 5.Results The study will open for recruitment in October 2023, and data collection is expected to be completed by November 2024. The results for the primary outcomes are planned to be analysed by December 2024 and submitted for publication by the end of the project in March 2025.
- 6.Discussion The study will test whether the TCS intervention has a positive effect, not only in terms of reducing self-seeking potential sexual offenders' problematic sexual behaviours, but also on measures such as psychological wellbeing in CSAM users. Possible adverse effects of TCS intervention will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2023
CompletedFirst Submitted
Initial submission to the registry
November 14, 2024
CompletedFirst Posted
Study publicly available on registry
January 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedFebruary 24, 2025
February 1, 2025
1.3 years
November 14, 2024
February 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
proportion of patients with a reduction in the severity or duration of CSAM use
* Diminished severity or time spent in CSAM consumption: * Dichotomous outcome defined by a decrease of either a 50% or greater in time spent or of one level or greater of severity of the consumed materials, comparing week 1 and week 4. * Primary outcome assessment: * Severity (self-reported): o Adapted version of COPINE scale (Merdian et al., 2013): * Time (self-reported): * How much time did you spend in total using these materials during the last two weeks? (hh:mm)
At the end of waiting period and/or intervention, usually 4 to 6 weeks after onboarding and following up every two weeks up to 16 weeks after onboarding
Secondary Outcomes (3)
Frequency of CSAM consumption (self-reported)
every 2 weeks for 16 weeks after onboarding
Increased mental wellbeing (composite)
comparing week 1 and week 4
Total sexual outlet (self-reported)
every 2 weeks for 16 weeks after onboarding
Study Arms (2)
Waitlist
NO INTERVENTIONControl group: Waitlist.
TCS Intervention
EXPERIMENTALInterventions
Online Therapy Chat Service (TCS) based on CBT techniques from the Berlin Dissexuality Therapy (Beier, K. M. (2021). Pedophilia, hebephilia and sexual offending against children. The Berlin Dissexuality Therapy (BEDIT). Springer).
Eligibility Criteria
You may qualify if:
- Adult participant (≥18 years);
- use of CSAM in the previous 2 weeks;
- English, German, Czech, Spanish or Portuguese speaker;
- voluntary participation and agreement with the terms of the study.
You may not qualify if:
- Having severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual capabilities, untreated drug or alcohol addiction);
- current inpatient psychiatric stays and/or any other current treatment for CSAM behaviour;
- CSA perpetration history (past or present);
- currently under a criminal investigation, proceeding, punishment or probation status for committing online or offline CSA or CSAM use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charite University, Berlin, Germanylead
- Universitat Internacional de Catalunyacollaborator
- National Institute of Mental Health (NIMH)collaborator
- University of Trás-os-Montes and Alto Dourocollaborator
Study Sites (2)
Charite - Universitätsmedizin Berlin
Berlin, 10117, Germany
UIC
Barcelona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. Dr. phil.
Study Record Dates
First Submitted
November 14, 2024
First Posted
January 9, 2025
Study Start
October 24, 2023
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
February 24, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share